Highlights and Quick Summary
- Shareholders Equity and Liabilities (Total) for the quarter ending June 30, 2023 was $2.18 Billion (a -26.14% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity and Liabilities (Total) decreased by -25.09%
- Annual Shareholders Equity and Liabilities (Total) for 2022 was $3.17 Billion (a 7.02% increase from previous year)
- Annual Shareholders Equity and Liabilities (Total) for 2021 was $2.96 Billion (a 2.63% increase from previous year)
- Annual Shareholders Equity and Liabilities (Total) for 2020 was $2.88 Billion (a 23.89% increase from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity and Liabilities (Total) of Emergent Biosolutions Inc.
Most recent Shareholders Equity and Liabilities (Total)of EBS including historical data for past 10 years.Interactive Chart of Shareholders Equity and Liabilities (Total) of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Shareholders Equity and Liabilities (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $2,178.8 | $2,949.8 | – | – | – |
| 2022 | $3,166.6 | $2,908.5 | $2,735.4 | $2,780.4 | $3,166.6 |
| 2021 | $2,959.0 | $2,867.5 | $2,915.2 | $2,900.1 | $2,959.0 |
| 2020 | $2,883.2 | $2,616.3 | $2,466.1 | $2,278.7 | $2,883.2 |
| 2019 | $2,327.3 | $2,333.8 | $2,321.3 | $2,153.7 | $2,327.3 |
| 2018 | $2,229.4 | $1,173.62 | $1,138.89 | $1,068.47 | $2,229.4 |
| 2017 | $1,070.2 | $1,024.2 | $970.48 | $951.64 | $1,070.2 |
| 2016 | $970.11 | $932.03 | $1,056.47 | $1,035.9 | $970.11 |
| 2015 | $1,037.48 | $976.55 | $943.32 | $917.85 | $1,037.48 |
| 2014 | $938.69 | $869.29 | $837.25 | $823.25 | $938.69 |
| 2013 | $626.63 | $595.46 | $555.61 | $538.39 | $626.63 |
| 2012 | $564.23 | $540.03 | – | – | $564.23 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic